Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates Sorrento Therapeutics has signed a research testing agreement with the University of Texas Medical Branch at Galveston in the US for preclinical studies of Covid-19 drug candidates.
The testing will take place in the laboratory of Dr Slobodan Paessler at the University of Texas Medical Branch. Paessler is the scientific director of the Animal Biosafety Laboratory 3 at the Galveston National Laboratory.
The researcher has experience in viral pathogenesis and therapeutic agent development. Sorrento Therapeutics CEO and chairman Dr Henry Ji said: “Dr Paessler is a world-renowned expert in infectious diseases and the development of animal models to test new